Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...

CSL shares remain down 35.2% over the past year, impacted by concerns over vaccine sales and strategic changes. Analyst John Athanasiou from Red Leaf Securities suggests CSL shares are oversold, ...

Three years after introducing Hemgenix, the first gene therapy for hemophilia B, CSL Behring has released long-term data proving the treatment’s benefits remain durable after five years. The five-year ...

uniQure and CSL have become the first pharma companies to get regulatory approval for a gene therapy for haemophilia B anywhere in the world, after the FDA cleared their Hemgenix therapy for adults ...

Australia's CSL, which earlier this year paused plans to put its CSL Seqirus vaccine division up for sale, has opened the doors to a new $1 billion cell-based influenza vaccine and antivenom ...

BMW says M is the most powerful letter in the world, but the addition of the letters CSL makes it both more powerful and lighter too. That basically sums up the M4 CSL, which cranks performance and ...

Matt Williams and Emma Fisher’s $1 billion Australian Share Fund returned just 3.2 per cent last year as it avoided the rally in gold stocks and got hit by a sell-off in CSL.

The E36-generation BMW M3 tends to get overlooked. Not this one. Lightened with carbon fiber and imbued with more than 300 horsepower from its naturally aspirated straight-six engine, it's a Group A ...

Declasse Tampa GT GTA$1,380,000 GTA$1,400,000 Southern San Andreas Super Autos Declasse Vigero ZX GTA$1,947,000 GTA$550,000 Southern San Andreas Super Autos Declasse Vigero ZX Convertible ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...